References
- Cannistra SA, Niloff JM. Cancer of the uterine cervix. N Eng1J Med 1996;334:1030–7
- Salazar EL, Gonzalez SJ, Galindo VA, et al. Estro-gen receptor in dysplastic and malignant cervical tissue: expression, localisation and prognostic significance. Med Sci Res 1996;24:523–4
- Kjaer SK, Brinton LA. Adenocarcinomas of the uterine cervix: the epidemiology of an increasing problem. Epidemiol Rev 1993;15:486–98
- Leslie KO, Silverberg SG. Microglandular hyper-plasia of the cervix. Unusual clinical and pathologic presentation and their differential diagnosis. Progr Surg Pathol 1984;5:95–114
- Jones MW, Silverberg SG. Cervical adeno-carcinoma in young women: possible relationship to microglandular hyperplasia and use of oral contraceptives. Obstet Gynecol 1989;73:984–8
- Brinton LA. Oral contraceptives and cervical neoplasia. Contraception 1991;43:581–95
- Pater A, Bayatpour M, Pater MM. Oncogenic transformation by human papillomavirus type 16 deoxyribonucleic acid in the presence o fprogester-one or progestins from oral contraceptives. Am J Obstet Gynecol 1990;62: 1099–103
- Fujiwara H, Tortolero-Luna G, Mitchell MF, et al. Adenocarcinoma of the cervix. Expression and clinical significance of estrogen and progesterone receptors. Cancer 1997;79:505–12
- Atlas I, Grajewuski W, Falkenberry S, et al. Absence of estrogen and progesterone receptors in glassy cell carcinoma of the cervix. Obstet Gynecol 1998;91:136–8
- Scambia G, Panici PB, Baiocchi G, et al. Steroid hormone receptors in carcinoma of the cervix: lack of response to an antiestrogen. Gynecol Oncol 1990; 37:323–6
- zur Hausen H. Human genital cancer: synergism between two virus infections or synergism b etween a virus infection and initiating events? Lancet 1982; 2:1370–2
- Porias H, Carranco LA, Sojo AT, et al. Hormonal content of plasma and endometrium of women taking oral contraception. Obstet Gynecol 1978; 52:703–7
- Salazar EL, Roman AM, Gonzalez SJ. Hormone receptor status in cervical intraepithelial neoplasia: correlation with the stage of disease. Med Sci Res 1999;27:681–3
- Salazar EL, Roman AM, Gonzalez SJ. Progester-one receptor values in human papillomavirus infection and cervical intraepithelial neoplasia. Med Sci Res 1997;25:511–12
- Scatchard G. The attraction of protein for small molecules and ions. Ann NY Acad Sci 1949;51: 660–72
- Lowry OH, Rosenbrough NJ, Farr L, et al. Protein measurement with the folin phenol reagent. J Biol Chem 1951;193:265–75
- Gram IT, Macaluso M, Stalsberg H. Oral contra-ceptive use and the incidence of cervical intra-epithelial neoplasia. Am J Obstet Gynecol 1992;167: 40–4
- Bhattacharya D, Redkar A, Mittra I, et al. Oestro-gen increases S-phase fraction and oestrogen and progesterone receptors in human cervical cancer in vivo. Br J Cancer 1997;75:554–8
- Murphy IT Growth factors and steroid hormone action in endometrial cancer. J Steroid Biochem Molec Biol 1994;48:419–23
- Hildesheim A, Reeves WC, Brinton L, et al. Association of oral contraceptive use and human papillomavirus in invasive cervical cancers. Int J Cancer 1990;45:860–4
- Gloss B, Bernard HU, Seedorf K, et al. The upstream regulatory region of the human-papilloma-virus-16 contains an E2-protein-independent enhancer which is specific for cervical carcinoma cells and regulated by glucocorticoid hormones. EMBO J 1987;6:3735–43
- Mitrani-Rosenbaum S, Tsvieli R, Tur-Kaspa R. Estrogen but not gluco corticoids stimulate HPV-16 transcription in SIHA cells. Proceedings of the Seventh International Papillomavirus Workshop, Nice, France 1988;82
- Auborn KJ, Woodworth C, DiPaolo JA, Bradlow HL. The interaction between HPV infection and estrogen metabolism in cervical carcino genesis. Int J Cancer 1991;49:867–9
- Monsonego J, Magdalenat H, Catalan F, et al. Estrogen and progesterone receptors in cervical human papillomavirus related lesions. Int J Cancer 1991;48:533–9
- Bosch FX, Munoz N, de Sanjose S, et al. Risk factors for cervical cancer in Colombia and Spain. Int J Cancer 1992;52:750–8
- Eluf-Neto J, Booth M, Munoz N, et al. Human papillomavirus and invasive cancer in Brazil. Br J Cancer 1994;69:114–9
- Catherino WH, WolfDM, Jordan VC. A naturally occurring estrogen receptor mutation results in increased estrogenicity o f a Tamoxifen analog. Mol Endocrinol 1995;9:1053–63